|
Magnesium Hydroxide |
|
Trade Name: |
MOM |
|
Therapeutic Class: |
56:12 Cathartics and Laxatives |
|
Contraindications: |
Hypersensitivity to magnesium hydroxide or any component |
|
Usual Dosage |
|
Adults: |
|
Oral: |
Antacid - 5 to 15 ml by mouth up to four times daily with water
Laxative - 30 to 60 ml by mouth daily with water |
|
Dosage Form |
|
Liquid: |
400 mg/5 ml |
|
Authorized Prescribers: |
MD/NP/PA/RN |
|
Comments: |
MD/NP/PA/RN: as per guidelines. Above dosages are for 400mg/5 ml strength. Do NOT consfuse with Concentrate (800mg/5 ml) |
|
Magnesium Sulfate |
|
Trade Name: |
Magnesium Sulfate |
|
Therapeutic Class: |
28:12.92 Miscellaneous Anticonvulsants |
|
Contraindications: |
Heart block or myocardial damage; serious renal impairment |
|
Usual Dosage |
|
Hypomagnesemia: |
|
|
Adults: |
|
Oral: |
3 grams every 6 hours for 4 doses as needed |
|
IM, IV: |
1 gram every 6 hours for 4 doses or IV: 250 mg/kg over a 4 hours period or 8-12 grams magnesium sulfate/24 hours in divided doses |
|
Dosage Form |
|
Injectable: |
12.5% solution of magnesium sulfate |
|
Authorized Prescribers: |
MD only |
|
Comments: |
None |
|
Measles, Mumps, and Rubella Vaccine |
|
Trade Name: |
MMR |
|
Therapeutic Class: |
80:12 Vaccines |
|
Contraindications: |
Known hypersensitivity to drug, hypersensitivity to neomycin, acute respiratory illness, active untreated tuberculosis, immunosuppressive therapy, immunodeficiency
states, hematologic or lymphogenous malignancy. |
|
Usual Dosage |
|
See DIHS SOP 8.16.01 |
|
Dosage Form |
|
Injection: |
single-dose |
|
Authorized Prescribers: |
MD/NP/PA/RN |
|
Comments: |
MD/NP/PA/RN: as per guidelines |
|
Mebendazole |
|
Trade Name: |
Vermox |
|
Therapeutic Class: |
08:08 Anthelmintics |
|
Contraindications: |
Hypersensitivity to mebendazole or any component |
|
Usual Dosage |
|
Adults: |
|
Pinworms: |
Single chewable tablet; may need to repeat after 2 weeks |
|
Whipworms, roundworms, and hookworms: |
One tablet twice daily, morning and evening on 3 consecutive days; if patient is not cured within 3-4 weeks a second course of treatment may be administered |
|
Dosage Form |
|
Tablet: |
100 mg |
|
Authorized Prescribers: |
MD/NP/PA |
|
Comments: |
NP/PA: E. vermicularis |
|
Meclizine |
|
Trade Name: |
Antivert |
|
Therapeutic Class: |
56:22 Antiemetics |
|
Contraindications: |
Hypersensitivity to meclizine or any component; pregnancy |
|
Usual Dosage |
|
Adults: |
|
Vertigo: |
25-100 mg/day in divided doses |
|
Motion Sickness: |
25-50 mg 1 hour before travel, repeat dose every 24 hours if needed |
|
Dosage Form |
|
Tablet: |
12.5 mg, 25 mg, 50 mg |
|
Authorized Prescribers: |
MD/NP/PA |
|
Comments: |
NP/PA: Vertigo |
|
Medroxyprogesterone |
|
Trade Name: |
Provera |
|
Therapeutic Class: |
68:32 Progestins |
|
Contraindications: |
Women with undiagnosed abnormal uterine bleeding, hemorrhagic diathesis, known or suspected pregnancy, active hepatic disease, active thrombophlebitis, thromboembolic
disorders, or known or suspected carcinoma of the breast. |
|
Usual Dosage |
|
Adults: |
|
Oral: |
5-10 mg daily for ten days |
|
Dosage Form |
|
Tablet: |
2.5 mg, 5 mg, 10 mg |
|
Authorized Prescribers: |
MD/NP/PA |
|
Comments: |
NP/PA: Secondary amenorrhea and osteoporosis |
|
Meperidine Hydrochloride |
|
Trade Name: |
Demerol |
|
Therapeutic Class: |
28:08.08 Opiate Agonists |
|
Contraindications: |
Hypersensitivity to meperidine or any component |
|
Usual Dosage |
|
Adults: |
|
Oral, IM, IV, SC: |
50-150 mg/dose every 3-4 hours as needed |
|
Dosage Form |
|
Injection: |
25 mg/ml, 50 mg/ml, 100 mg/ml |
|
Authorized Prescribers: |
MD/DDS/NP/PA |
|
Comments: |
NP/PA: Nephrolithiasis; Note: Physician must approve and co-sign written prescription ASAP Keep in locked cabinet. |
|
Mepivacaine |
|
Trade Name: |
Carbocaine |
|
Therapeutic Class: |
72:00 Local Anesthetics |
|
Contraindications: |
Hypersensitivity to mepivacaine or any component; pregnancy |
|
Usual Dosage |
|
Adults: |
|
Injection: |
use as per dental protocol; maximum dose 7 mg/kg or 400 mg whichever is less |
|
Dosage Form |
|
Injection: |
3% solution |
|
Authorized Prescribers: |
MD/DDS only |
|
Comments: |
None |
|
Metaraminol |
|
Trade Name: |
Aramine |
|
Therapeutic Class: |
12:12 Sympathomimetic (Adrenergic) Agents |
|
Contraindications: |
Known hypersensitivity to metaraminol or other sympathomimetic agents |
|
Usual Dosage |
|
Adults: |
|
IV: |
1.5-10 mcg/kg/min |
|
Dosage Form |
|
Injection: |
10 mg/ml |
|
Authorized Prescribers: |
MD only |
|
Comments: |
None |
|
Metformin |
|
Trade Name: |
Glucophage |
|
Therapeutic Class: |
68:20.92 Miscellaneous Antidiabetic Agents |
|
Contraindications: |
Hypersensitivity to metformin or any component; renal or liver disease, heart failure, pulmonary insufficiency, pregnancy and alcoholism |
|
Usual Dosage |
|
Adults: |
|
Oral: |
Initial dosage 850 mg once daily or 500 mg twice daily. |
|
|
Maintenance dosage Must be individualized on basis of effectiveness and tolerance. Maximum Dose 2550 mg/day |
|
Dosage Form |
|
Tablet: |
500 mg, 850 mg |
|
Authorized Prescribers: |
MD/NP/PA |
|
Comments: |
Second line agent for patients unable to take insulin or tolerate sulfonylureas |
|
Methocarbamol |
|
Trade Name: |
Robaxin |
|
Therapeutic Class: |
12:20 Muscle Relaxants |
|
Contraindications: |
Renal impairment, hypersensitivity to methocarbamol or any component |
|
Usual Dosage |
|
Adults: |
|
Oral: |
1.5 grams 4 times/day for 2-3 days, then decrease to 4-4.5 grams/day in 3-6 divided doses |
|
Dosage Form |
|
Tablet: |
500 mg, 750 mg |
|
Authorized Prescribers: |
MD/NP/PA |
|
Comments: |
NP/PA: Lumbosacral strain, cervical neck sprain and headaches |
|
Methylcellulose Ophthalmic |
|
Trade Name: |
Tears Naturale |
|
Therapeutic Class: |
52:36 Miscellaneous EENT Drugs |
|
Contraindications: |
Hypersensitivity to methylcellulose or any component |
|
Usual Dosage |
|
Adults: |
|
Ophthalmic: |
2-5 drops every 2-3 hours as needed for eye irritation |
|
Dosage Form |
|
Ophthalmic: |
Solution |
|
Authorized Prescribers: |
MD/NP/PA/RN |
|
Comments: |
NP/PA/RN: Eye irritation |
|
Methyldopa |
|
Trade Name: |
Aldomet |
|
Therapeutic Class: |
24:08 Hypotensive Agents |
|
Contraindications: |
Hypersensitivity to methyldopa or any component; liver disease;
pheochromocytoma. |
|
Usual Dosage |
|
Adults: |
|
Oral: |
250-500 mg 2-3 times/day, up to 3 grams/24 hours |
|
Dosage Form |
|
Tablet: |
125 mg, 250 mg, 500 mg |
|
Authorized Prescribers: |
MD only |
|
Comments: |
None |
|
Methylprednisolone |
|
Trade Name: |
Solu-Medrol, Medrol |
|
Therapeutic Class: |
68:04 Adrenals |
|
Contraindications: |
Hypersensitivity to methylprednisolone or any component; administration of live virus vaccine, systemic fungal infection. |
|
Usual Dosage |
|
Children |
|
Anti-inflammatory: |
|
IM, IV: |
0.16-1.0 mg/kg/24 hours |
|
Status asthmaticus: |
|
IV: Loading: |
2 mg/kg as a single dose |
|
Maintenance: |
0.5-1.0 mg/kg/dose every 6 hours |
|
Adults: |
|
Oral: |
2-60 mg in 1-4 divided doses |
|
IM: |
10-80 mg/24 hours once daily |
|
Dosage Form |
|
Injection, as sodium succinate: |
1 gram |
|
Tablet: |
2 mg, 4 mg, 8 mg, 16 mg, 24 mg, 32 mg |
|
Authorized Prescribers: |
MD/NP/PA |
|
Comments: |
NP/PA: Anaphylaxis in infant/children, asthma in adults |
|
Metoclopramide Hydrochloride |
|
Trade Name: |
Reglan |
|
Therapeutic Class: |
56:40 Miscellaneous GI Drugs |
|
Contraindications: |
Hypersensitivity to metoclopramide or any component; GI obstruction, pheochromocytoma, history of seizure disorder. |
|
Usual Dosage |
|
Adults: |
|
Oral: |
10-15 mg/dose up to 4 times/day, 30 minutes before each meal and at bedtime |
|
Dosage Form |
|
Tablet: |
5 mg, 10 mg |
|
Authorized Prescribers: |
MD/NP/PA |
|
Comments: |
NP/PA: For hiatal hernia and reflux |
|
Metronidazole |
|
Trade Name: |
Flagyl and Metrogel |
|
Therapeutic Class: |
08:40 Miscellaneous Anti-infective 84:04.16 Miscellaneous Local Anti-Infectives |
|
Contraindications: |
Hypersensitivity to metronidazole or any component |
|
Usual Dosage |
|
Children |
|
Amebiasis: |
35-50 mg/kg/24 hours in divided doses every 8 hours |
|
Other parasitic infections: |
15-30 mg/kg/24 hours in divided doses every 8 hours |
|
Anaerobic infections: |
30 mg/kg/24 hours in divided doses every 6 hours |
|
Clostridium difficile: |
20 mg/kg/24 hours divided every 6 hours
Maximum dose: 2 grams/24 hours |
|
|
|
|
Adults: |
|
Amebiasis: |
500-750 mg every 8 hours |
|
Other parasitic infections: |
50 mg every 8 hours or 2 grams as a single dose |
|
Anaerobic infections: |
30 mg/kg/24 hours in divided doses every 6 hours, not to exceed 4 grams/24 hours |
|
Antibiotic associated colitis: |
250 mg 4 times/day for 10-14 days Bacterial vaginosis: 0.75% gel intra-vaginally twice a day for 5 days |
|
Dosage Form |
|
Tablet: |
250 mg |
|
Gel: |
0.75% vaginal gel |
|
Authorized Prescribers: |
MD/NP/PA |
|
Comments: |
NP/PA can use oral medication for trichomonal and gardnerella vaginitis, bacterial vaginosis; can use intra-vaginal gel to treat Gardnerella Vaginalis in
patients unable to tolerate triple sulfa cream; can also use gel to treat Rosacea |
|
Mirtazapine |
|
Trade Name: |
Remeron |
|
Therapeutic Class: |
28:16.04 Antidepressants |
|
Contraindications: |
Hypersensitivity to mirtazapine or any component. |
|
Usual Dosage |
|
Adults: |
|
Oral: |
Starting dose 15 gm/day preferably in the evening |
|
Dosage Form |
|
Tablet: |
15 mg, 30 mg, 45 mg |
|
Authorized Prescribers: |
Psychiatry only |
|
Comments: |
None |
|
Morphine Sulfate |
|
Trade Name: |
Duramorph |
|
Therapeutic Class: |
28:08.08 Opiate Agonists |
|
Contraindications: |
Known hypersensitivity to morphine sulfate; increased intracraninal pressure; severe respiratory depression; severe liver or renal insufficiency. |
|
Usual Dosage |
|
Adults: |
|
IM, IV, SC: |
2.5-20 mg/dose every 2-6 hours as needed
IV, SC continuous infusion: 0.8-80 mg/hour |
|
Dosage Form |
|
Injection: |
8 mg/ml, 10 mg/ml, 15 mg/ml |
|
Authorized Prescribers: |
MD only |
|
Comments: |
Keep in locked cabinet. |
|
Multivitamin |
|
Trade Name: |
One-A-Day |
|
Therapeutic Class: |
88:28 Multivitamin Preparation |
|
Contraindications: |
Hypersensitivity to any component |
|
Usual Dosage |
|
Oral: |
1 tablet/ day |
|
Dosage Form |
|
Tablet: |
1 multivitamin |
|
Authorized Prescribers: |
MD/NP/PA/RN |
|
Comments: |
NP/PA/RN: Vitamin deficiency |
|
Multivitamin/Mineral/Folic Acid |
|
Trade Name: |
Prenatal Vitamin |
|
Therapeutic Class: |
88:28 Multivitamin Preparation |
|
Contraindications: |
Hypersensitivity to any component |
|
Usual Dosage |
|
Adults: |
|
Oral: |
1 tablet/day |
|
Dosage Form |
|
Tablet: |
1 prenatal vitamin |
|
Authorized Prescribers: |
MD/NP/PA |
|
Comments: |
None |
|
Mumps Skin Test Antigen |
|
Trade Name: |
MSTA |
|
Therapeutic Class: |
36:52 Mumps (Diagnostic) |
|
Contraindications: |
Persons with ovian protein (eggs or egg products) sensitivity, known hypersensitivity to thimerosal. |
|
Usual Dosage |
|
Must be given intradermally if it is given SC no reaction or an unreliable reaction may occur. |
|
Children and Adults: |
|
0.1 ml intradermally into flexor surface of the forearm; examine reaction site in 24-48 hours; a positive reaction is >1.5 mm diameter induration; pseudopositive reaction may develop in persons sensitive to egg protein; a positive reaction indicates sensitivity; a negative reaction probably indicates either anergy or nonsenstivity. |
|
Dosage Form |
|
Injection: |
10 doses/1 ml vial |
|
Authorized Prescribers: |
MD/NP/PA/RN |
|
Comments: |
Diagnostic agent for anergy testing; vials need to be refrigerated. |
|
|
|
|
|
|
|
|
|